ESG vs GLP-1 Medications

GLP-1 medications work through signaling. They change appetite and how full you feel, and they keep working while you keep taking them.

ESG works through structure. The stomach is reshaped from the inside so it holds less and empties more slowly. The change stays in place without a weekly prescription.

One is ongoing therapy. One is a procedure. Neither treats metabolic disease as a matter of willpower, because it is not.

Medication asks for consistency and tolerance. Side effects like nausea are common early. Access and supply can be unpredictable. If the medication stops, the signal it was providing stops with it.

ESG asks for a single procedure day, a short recovery, and a staged diet afterward. It also asks for follow-up, because the structural change works best alongside real nutrition support.

Both reduce how much food it takes to feel satisfied. Both work better with nutrition support than without it. Both address physiology rather than blaming effort.

Because they overlap, they can be layered. Some people use medication before a procedure. Some use it afterward when progress stalls. That is a clinical decision, not a fixed rule.

If you have not tried a medically supervised medication plan, if your health picture is early, or if you cannot take any recovery time right now, starting with medication is reasonable.

It also gives useful information. How your body responds to a change in appetite signaling tells us something about what a structural change might do.

If medication has not been tolerated, if access has been unreliable, or if you want a change that does not depend on staying on a drug indefinitely, a procedure deserves consideration.

It is also worth considering if you have plateaued on medication and the plan has become maintenance rather than progress.

This page is educational. It is not medical advice and it does not replace an evaluation. What is right for you depends on your history, your testing, and a conversation with a surgeon.